Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, bio-pharmaceuticals, production and sale of III and IV cephalosporin intermediates. Its products are categorized into the following divisions: Characteristic Bulk Drugs, Pharmaceutical Intermediates, and Fine Chemicals. The company was founded by Hong Fu Zhao on January 12, 2004 and is headquartered in Zibo, China.